Oligonucleotide Chemistry Group Lead

A*STAR - Agency for Science, Technology and Research; Singapore; On-site; SGD 100,000 - 150,000; Full time

Benefits offered by this job

Attractive benefits

Long-term career growth opportunities

Job summary

A leading biotechnology initiative in Singapore is seeking a Group Leader for Oligonucleotides Chemistry to oversee pre-clinical synthesis and lead a team. This role requires extensive experience in oligonucleotide and synthetic chemistry, and strong leadership skills. The successful candidate will drive the development of innovative RNA-based therapeutics. This opportunity offers competitive compensation and the chance to contribute to Singapore's status as a hub for nucleic acid therapeutics.

Qualifications

• A minimum of 7+ years of hands-on experience in modern synthetic chemistry.
• Extensive experience with oligonucleotide synthesis and analysis.
• Demonstrated leadership and communication skills.

Responsibilities

• Oversee oligonucleotide chemistry capabilities and workflows.
• Build and manage a high-performing team of scientists.
• Collaborate with various teams on drug candidate selection.
• Expand oligonucleotide platform capabilities and innovate.
• Prepare reports and presentations for leadership.

Skills

Modern synthetic chemistry methods

Leadership and mentorship

Collaboration in cross-functional teams

Oligonucleotide chemistry capabilities

Problem-solving skills

Education

Doctorate degree in Chemistry or related field

Tools

SPOS instrumentation

Analytical platforms

Purification systems

Job description

A leading biotechnology initiative in Singapore is seeking a Group Leader for Oligonucleotides Chemistry to oversee pre-clinical synthesis and lead a team. This role requires extensive experience in oligonucleotide and synthetic chemistry, and strong leadership skills. The successful candidate will drive the development of innovative RNA-based therapeutics. This opportunity offers competitive compensation and the chance to contribute to Singapore's status as a hub for nucleic acid therapeutics.